Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow changed -38.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current liabilities changed +121.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed +47.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed -437.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +42.1% from the comparable as-filed period.
Working capital / assets changed -6048 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed -69.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +42704 basis points from the comparable as-filed period.
Gross margin changed +6428 basis points from the comparable as-filed period.
Revenue changed +445.3% from the comparable as-filed period.
Current assets changed -31.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Total assets changed -34.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Research & development changed -46.7% from the comparable as-filed period.
Cash & equivalents changed +64.8% from the comparable as-filed period.
Stock-based compensation changed -65.6% from the comparable as-filed period.
Cost of revenue changed +142.9% from the comparable as-filed period.
Trade receivables changed +81.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory / revenue changed -33463 basis points from the comparable as-filed period.
SBC / revenue changed -18446 basis points from the comparable as-filed period.
Operating cash-flow margin changed +13444 basis points from the comparable as-filed period.
R&D / revenue changed -5766 basis points from the comparable as-filed period.
Receivables / revenue changed -9638 basis points from the comparable as-filed period.
Gross profit changed +1757.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Shares outstanding changed +4.7% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.